Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Jansen

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
The New England Journal of Medicine|April 13, 2022
Rilzabrutinib, an Oral BTK Inhibitor, in Immune ThrombocytopeniaDavid J Kuter, Merlin Efraim, Jiri Mayer, et al.
The New England Journal of Medicine|May 24, 2023
Platelet Transfusion before CVC Placement in Patients with ThrombocytopeniaFloor L F van Baarle, Emma K van de Weerdt, Walter J F M van der Velden, et al.
BMC Pregnancy and Childbirth|December 18, 2010
Well being of obstetric patients on minimal blood transfusions (WOMB trial)Babette W Prick, Eric A P Steegers, A J Gerard Jansen, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
The New England Journal of Medicine|April 13, 2022
Rilzabrutinib, an Oral BTK Inhibitor, in Immune ThrombocytopeniaDavid J Kuter, Merlin Efraim, Jiri Mayer, et al.
The New England Journal of Medicine|May 24, 2023
Platelet Transfusion before CVC Placement in Patients with ThrombocytopeniaFloor L F van Baarle, Emma K van de Weerdt, Walter J F M van der Velden, et al.
BMC Pregnancy and Childbirth|December 18, 2010
Well being of obstetric patients on minimal blood transfusions (WOMB trial)Babette W Prick, Eric A P Steegers, A J Gerard Jansen, et al.
Pageof 6